Home Featured Page 203

Featured

Latest

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive...

Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts...

PharmaTher Announces Positive Research Results for LSD Microneedle Patch

Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of...

Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants...

PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative...

MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer

MAPS and Wesana Health Resume Negotiations

Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté...

MindMed Appoints Robert Barrow as Chief Executive Officer and Director

1...202203204...308 Page 203 of 308

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive...

Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts...

PharmaTher Announces Positive Research Results for LSD Microneedle Patch

Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of...

Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants...

PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative...

MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer

MAPS and Wesana Health Resume Negotiations

Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté...

MindMed Appoints Robert Barrow as Chief Executive Officer and Director

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY